National Institute of Neurological Disorders and Stroke; Notice of Meeting, 22425-22426 [E8-9012]

Download as PDF Federal Register / Vol. 73, No. 81 / Friday, April 25, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel LIRR and RIBT Member Conflicts 1. Date: May 1, 2008. Time: 3:30 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call). Contact Person: George M. Barnas, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD 20892, 301–435– 0696, barnasg@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 17, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9000 Filed 4–24–08; 8:45 am] sroberts on PROD1PC70 with NOTICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Neurotoxicology and Alcohol Study Section, June 3, 2008, 8 a.m. to June 4, 2008, 5 p.m., Sir Francis Jkt 214001 BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, May 15, 2008, 10 a.m., to May 16, 2008, 8 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on April 11, 2008, 73 FR 19855–19857. The meeting will be held one day only, May 16, 2008, from 11 a.m. to 4 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: April 17, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9002 Filed 4–24–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Center for Scientific Review; Amended Notice of Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES 20:20 Apr 24, 2008 Dated: April 17, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9001 Filed 4–24–08; 8:45 am] National Institutes of Health BILLING CODE 4140–01–M VerDate Aug<31>2005 Drake Hotel, 450 Powell Street, San Francisco, CA 94102, which was published in the Federal Register on April 4, 2008, 73 FR 18539–18542. The meeting will be held one day only June 3, 2008. The meeting time and location remain the same. The meeting is closed to the public. Notice is hereby given of a change in the meeting of the Hematopoiesis Study Section, June 5, 2008, 8 a.m. to June 6, 2008, 11 a.m., Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD, 20814, which was published in the Federal Register on April 11, 2008, 73 FR 19855–19857. The meeting will be held one day only June 5, 2008, from 8 a.m. to 7 p.m. The meeting location remains the same. The meeting is closed to the public. PO 00000 Frm 00105 Fmt 4703 Sfmt 4703 22425 Dated: April 17, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9005 Filed 4–24–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Muscular Dystrophy Coordinating Committee (MDCC). The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the Contact Person listed below in advance of the meeting. Name of Committee: Muscular Dystrophy Coordinating Committee. Date: June 23, 2008. Time: 8 a.m. to 5 p.m. Agenda: The 2008 meeting of the MDCC will focus on the themes of therapy development and living with muscular dystrophy. MDCC members will review their activities related to the goals of the Action Plan for the Muscular Dystrophies which can be found on the MDCC website listed below. Other activities planned for the meeting include a presentation on opportunities for therapy development in myotonic dystrophy, a discussion of muscular dystrophy workforce needs, and a discussion of recent successful collaborations and new opportunities for partnering among the muscular dystrophy community, including the Fields Center for FSHD and Neuromuscular Disease and the Translational Research in Europe—Assessment and Treatment of Neuromuscular Disease (TREAT–NMD) network. An agenda will be posted prior to the meeting on the MDCC Web site: https://www.ninds.nih.gov/ find_people/groups/mdcc/index.htm. Place: Washington Plaza Hotel, 10 Thomas Circle, NW., Washington, DC 20005. Contact Person: John D. Porter, PhD, Executive Secretary, Muscular Dystrophy Coordinating Committee, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, NSC 2172, Bethesda, MD 20892, (301) 496–5739, porterjo@ninds.nih.gov. Any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. E:\FR\FM\25APN1.SGM 25APN1 22426 Federal Register / Vol. 73, No. 81 / Friday, April 25, 2008 / Notices (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: April 16, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9012 Filed 4–24–08; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting Notice is hereby given of a change in the meeting of the National Advisory Council for Biomedical Imaging and Bioengineering, May 16, 2008, 9 a.m. to 5 p.m., Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, Maryland 20817, which was published in the Federal Register on April 9, 2008, 73 FR 19230. The meeting start time has been changed from 9 a.m. to 8:30 a.m. The meeting location remains the same. Dated: April 17, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–9004 Filed 4–24–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health sroberts on PROD1PC70 with NOTICES National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of meetings of the National Diabetes and Digestive and Kidney Diseases Advisory Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections VerDate Aug<31>2005 20:20 Apr 24, 2008 Jkt 214001 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council. Date: May 23, 2008. Open: 8:30 a.m. to 12:30 p.m. Agenda: To present the Director’s Report and other scientific presentations. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room E1/E2, Bethesda, MD 20892. Closed: 3:45 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room E1/E2, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, PhD, Director Division of Extramural Activities, National Institutes of Diabetes and Digestive, and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney, Diseases Advisory Council, Diabetes, Endocrinology, and Metabolic Diseases Subcommittee. Date: May 23, 2008. Open: 1 p.m. to 2:15 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room E1/E2, Bethesda, MD 20892. Closed: 2:15 p.m. to 3:45 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room E1/E2, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, PhD, Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive, and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney, Diseases Advisory Council, Digestive Diseases and Nutrition Subcommittee. Date: May 23, 2008. Open: 1 p.m. to 2:15 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Closed: 2:15 p.m. to 3:45 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00106 Fmt 4703 Sfmt 4703 Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, PhD, Director Division of Extramural Activities, National Institutes of Diabetes and Digestive, and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney, Diseases Advisory Council Kidney, Urologic, and HematologicDiseases Subcommittee. Date: May 23, 2008. Open: 1 p.m. to 2:15 p.m. Agenda: To review the Division’s scientific and planning Activities. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room F1/F2, Bethesda, MD 20892. Closed: 2:15 p.m. to 3:45 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive Conference Room F1/F2, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, PhD, Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive, and Kidney Diseases, 6707 Democracy Blvd. Room 715, Msc 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.niddk.nih.gov/fund/divisions/DEA/ Council/coundesc.htm., where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: April 17, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–8985 Filed 4–24–08; 8:45 am] BILLING CODE 4140–01–M E:\FR\FM\25APN1.SGM 25APN1

Agencies

[Federal Register Volume 73, Number 81 (Friday, April 25, 2008)]
[Notices]
[Pages 22425-22426]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-9012]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Muscular Dystrophy Coordinating Committee (MDCC).
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should inform the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: June 23, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: The 2008 meeting of the MDCC will focus on the themes of 
therapy development and living with muscular dystrophy. MDCC members 
will review their activities related to the goals of the Action Plan 
for the Muscular Dystrophies which can be found on the MDCC website 
listed below. Other activities planned for the meeting include a 
presentation on opportunities for therapy development in myotonic 
dystrophy, a discussion of muscular dystrophy workforce needs, and a 
discussion of recent successful collaborations and new opportunities 
for partnering among the muscular dystrophy community, including the 
Fields Center for FSHD and Neuromuscular Disease and the 
Translational Research in Europe--Assessment and Treatment of 
Neuromuscular Disease (TREAT-NMD) network. An agenda will be posted 
prior to the meeting on the MDCC Web site: https://www.ninds.nih.gov/
find_people/groups/mdcc/index.htm.
    Place: Washington Plaza Hotel, 10 Thomas Circle, NW., 
Washington, DC 20005.
    Contact Person: John D. Porter, PhD, Executive Secretary, 
Muscular Dystrophy Coordinating Committee, National Institute of 
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard, 
NSC 2172, Bethesda, MD 20892, (301) 496-5739, 
porterjo@ninds.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.


[[Page 22426]]


(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: April 16, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-9012 Filed 4-24-08; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.